Results 61 to 70 of about 605 (157)

Update on the Discovery of Efflux Pump Inhibitors against Critical Priority Gram-Negative Bacteria. [PDF]

Antibiotics (Basel), 2023
Compagne N, Vieira Da Cruz A, Müller RT, Hartkoorn RC, Flipo M, Pos KM.   +5 more
europepmc   +1 more source

Probing antibacterial drugs for Fusobacterium nucleatum subsp. nucleatum ATCC 25586 targeting UDP-N-acetylglucosamine 1-carboxyltransferase. [PDF]

J Adv Pharm Technol Res, 2023
Saputri D, Mubarak Z, Mudatsir M, Setyawati I, Setiawan AG, Abrar M.   +5 more
europepmc   +1 more source

Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as novel microtubule destabilizers. [PDF]

J Enzyme Inhib Med Chem, 2021
Wang C, Li Y, Liu Z, Wang Z, Liu Z, Man S, Zhang Y, Bao K, Wu Y, Guan Q, Zuo D, Zhang W.   +11 more
europepmc   +1 more source

Synthesis, bioactivity, and molecular docking of novel arylpiperazine derivatives as potential AR antagonists. [PDF]

Front Chem, 2022
Qi Y, Chen H, Chen S, Shen J, Li J.
europepmc   +1 more source

Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter(SERT)and 5-HT1A receptors

, 2005
A new generation of antidepressant agents could be represented by compounds with mixed activity as serotonin transporter (SERT) inhibitors and 5-HT(1A) receptor antagonists.
COLABUFO, Nicola Antonio, LEOPOLDO, Marcello, PERRONE, Roberto, TORTORELLA V., BERARDI, Francesco, LARIZZA C., LACIVITA, ENZA   +6 more
core  

Influence of cellular lipid content on influenza A virus replication. [PDF]

Arch Virol, 2020
Limsuwat N, Boonarkart C, Phakaratsakul S, Suptawiwat O, Auewarakul P.   +4 more
europepmc   +1 more source

Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis. [PDF]

Front Oncol, 2021
Hipólito A, Martins F, Mendes C, Lopes-Coelho F, Serpa J.   +4 more
europepmc   +1 more source

σ₂ Receptor and Its Role in Cancer with Focus on a MultiTarget Directed Ligand (MTDL) Approach. [PDF]

Molecules, 2021
Abatematteo FS, Niso M, Lacivita E, Abate C.   +3 more
europepmc   +1 more source

Research progress on antitumor activity of XRP44X and analogues as microtubule targeting agents. [PDF]

Front Chem, 2023
Wang C, Shi L, Yang S, Chang J, Liu W, Zeng J, Meng J, Zhang R, Xing D.   +8 more
europepmc   +1 more source

A Multipronged Approach Establishes Covalent Modification of β-Tubulin as the Mode of Action of Benzamide Anti-cancer Toxins. [PDF]

J Med Chem, 2020
Povedano JM, Rallabandi R, Bai X, Ye X, Liou J, Chen H, Kim J, Xie Y, Posner B, Rice L, De Brabander JK, McFadden DG.   +11 more
europepmc   +1 more source